Supported by a grant from the Movember Foundation, the awards will fund research by six teams of investigators conducting innovative research on treatments and cures for prostate cancer....
NYS Entity Status
NYS Filing Date
SEPTEMBER 24, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION
2013 - OTTO HEINRICH WARBURG CANCER RESEARCH FOUNDATION INC.
AROUND THE WEB
- Prostate Cancer Foundation Awards $6 Million in 2017 Challenge Awards
By email@example.com (Kyoko Uchida) - Tuesday Aug 29, 2017
- Rutgers Receives $4 Million for Cancer Research Partnership
By firstname.lastname@example.org (Kyoko Uchida) - Wednesday Aug 23, 2017
The grants, which include $2 million from the Robert Wood Johnson Foundation, will enable RCI and the Center for Cancer Research to share knowledge and more rapidly advance discoveries leading to drug development, clinical trials, and new therapies for cancer patients....
- St. Baldrick's Foundation Awards $23.5 Million for Cancer Research
By email@example.com (Kyoko Uchida) - Thursday Jul 27, 2017
The ninety grants include $5.8 million to the Children's Oncology Group, whose two hundred member institutions treat more than 90 percent of children with cancer in the United States....
- NY AG presses TransUnion, Experian for cybersecurity details
By DAVID KLEPPER, Associated Press - Tuesday Sep 19, 2017
ALBANY, N.Y. (AP) — New York Attorney General Eric Schneiderman is pressing TransUnion and Experian to explain what cybersecurity they have in place to protect sensitive consumer information following a recent breach at Equifax that exposed the data of 143 million Americans.In letters to executives at the two credit monitoring companies, the Democratic attorney general asked them to describe their existing security systems as well as what changes they've made since the Equifax cyberattack."The unprecedented data breach experienced by Equifax Inc.
- 3 scientists, Planned Parenthood win Lasker medical prizes
By MALCOLM RITTER, AP Science Writer - Wednesday Sep 6, 2017
NEW YORK (AP) — Two scientists who paved the way for widely used vaccines and another who discovered key players in cell growth have been awarded prestigious medical research awards.The Albert and Mary Lasker Foundation also announced Wednesday that it was giving its public service award to Planned Parenthood. Each award includes a $250,000 honorarium.The foundation's clinical research award is shared by Dr. Douglas Lowy and John Schiller of the U.S. National Cancer Institute. In the early 1990s they began work that would eventually lead to vaccines against human papillomavirus, or HPV, which causes cervical cancer and some other cancers.
- Cancer drug research moving fast in immunotherapy field
By Michelle Fay Cortez - Tuesday Sep 5, 2017
The last few weeks have been historic in the fight against cancer. Novartis got approval for the first treatment in a revolutionary new class of drugs, shortly after Gilead Sciences Inc. spent $11.9 billion on a biotech company working in the field. Neither can rest on its laurels. Research in the field is moving so fast that today’s breakthroughs can easily become tomorrow’s has-beens. “I can’t think of any other therapies in oncology that have seen such rapid development,” said Rachel Webster, senior director of oncology at Decision Resources Group, a health care research and consulting firm in London.